Christopher Chen

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Guidepoint Global Advisors
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boxer Capital
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ADC Therapeutics
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Rain Oncology
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Kinnate Biopharma
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Oric Pharmaceuticals
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Mersana Therapeutics
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead Sciences
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merus
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seattle Genetics
    Date added:
    05/23/2023
    Date updated:
    09/27/2024
Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies